ASTELLAS PHARMA, INC. (ALPMF)
Clinical trial NCT03836209: completion date: 2026-12-01 → 2026-07-01.
SANOFI (SNYNF)
Clinical trial NCT07615192 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-05-26 → 2026-05-29
JOHNSON & JOHNSON (JNJ)
Clinical trial NCT04181827: completion date: 2029-04-09 → 2027-03-31.
MERCK & CO., INC. (MRK)
Clinical trial NCT07519772 updates: 1. completion date: 2030-10-21 → 2031-04-01 2. primary completion date: 2030-01-20 → 2030-07-01
THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. (TSOI)
Clinical trial NCT07357831: status: RECRUITING → ACTIVE_NOT_RECRUITING.
DiaMedica Therapeutics Inc (DMAC)
Press Release: DiaMedica Therapeutics Announces First Patients Dosed in Phase 2 Trial of DM199 for the Treatment of Fetal Growth Restriction
Nexalin Technology Inc (NXLIW)
Nexalin Technology Announces that the Investigator of Its Brazilian Clinical Trial Received the Young Researcher Award at BRAIN 2026 for Research Evaluating the Company’s Proprietary DIFS™ Platform
SCHWAB CHARLES CORP (SCHW)
Charles Schwab Recognized Among Nation’s Most Community-Minded Companies for 10th Consecutive Year
FINANCE OF AMERICA COMPANIES INC. (FOA)
Finance of America Expands Leadership Team to Accelerate Growth and Innovation
ALTERNATIVE BALLISTICS CORPORATION (ALBC)
Alternative Ballistics Corporation to Present at the Investor Summit Conference on June 24th